| ［1］ |
Chistiakov DA. Ligase Ⅳ syndrome［J］. Adv Exp Med Biol, 2010,685:175⁃185. doi: 10.1007/978⁃1⁃4419⁃6448⁃9_16.
|
| ［2］ |
Wei YF, Robins P, Carter K, et al. Molecular cloning and expression of human cDNAs encoding a novel DNA ligase Ⅳ and DNA ligaseⅢ, an enzyme active in DNA repair and recombination［J］. Mol Cell Biol, 1995,15（6）:3206⁃3216. doi: 10.1128/MCB.15.6.3206.
|
| ［3］ |
Unal S, Cerosaletti K, Uckan⁃Cetinkaya D, et al. A novel mutation in a family with DNA ligase Ⅳ deficiency syndrome［J］. Pediatr Blood Cancer, 2009,53（3）:482⁃484. doi: 10.1002/pbc.22031.
|
| ［4］ |
Buck D, Moshous D, de Chasseval R, et al. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase Ⅳ［J］. Eur J Immunol, 2006,36（1）:224⁃235. doi: 10.1002/eji.200535401.
|
| ［5］ |
Enders A, Fisch P, Schwarz K, et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase Ⅳ［J］. J Immunol, 2006,176（8）:5060⁃5068. doi: 10.4049/jimmunol. 176.8.5060.
|
| ［6］ |
van der Burg M, van Veelen LR, Verkaik NS, et al. A new type of radiosensitive T⁃B⁃NK+ severe combined immunodeficiency caused by a LIG4 mutation［J］. J Clin Invest, 2006,116（1）:137⁃145. doi: 10.1172/JCI26121.
|
| ［7］ |
Murray JE, Bicknell LS, Yigit G, et al. Extreme growth failure is a common presentation of ligase IV deficiency［J］. Hum Mutat, 2014,35（1）:76⁃85. doi: 10.1002/humu.22461.
|
| ［8］ |
Altmann T, Gennery AR. DNA ligase Ⅳ syndrome; a review［J］. Orphanet J Rare Dis, 2016,11（1）:137. doi: 10.1186/s13023⁃016⁃0520⁃1.
|
| ［9］ |
Sun B, Chen Q, Wang Y, et al. LIG4 syndrome: clinical and molecular characterization in a Chinese cohort［J］. Orphanet J Rare Dis, 2020,15（1）:131. doi: 10.1186/s13023⁃020⁃01411⁃x.
|
| ［10］ |
Jiang J, Tang W, An Y, et al. Molecular and immunological characterization of DNA ligase Ⅳ deficiency［J］. Clin Immunol, 2016,163:75⁃83. doi: 10.1016/j.clim.2015.12.016.
|
| ［11］ |
Riballo E, Doherty AJ, Dai Y, et al. Cellular and biochemical impact of a mutation in DNA ligase Ⅳ conferring clinical radiosensitivity［J］. J Biol Chem, 2001,276（33）:31124⁃31132. doi: 10.1074/jbc.M103866200.
|
| ［12］ |
Roddam PL, Rollinson S, O′Driscoll M, et al. Genetic variants of NHEJ DNA ligase Ⅳ can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination［J］. J Med Genet, 2002,39（12）:900⁃905. doi: 10.1136/jmg.39.12.900.
|
| ［13］ |
Cowan MJ, Gennery AR. Radiation⁃sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation⁃⁃what to do?［J］ J Allergy Clin Immunol, 2015,136（5）:1178⁃1185. doi: 10.1016/j.jaci.2015.04.027.
|
| ［14］ |
O′Driscoll M, Jeggo PA. CsA can induce DNA double⁃strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair［J］. Bone Marrow Transplant, 2008,41（11）:983⁃989. doi: 10.1038/bmt.2008.18.
|
